BCACU

Brookline Capital Acquisition Corp. [BCACU] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

BCACU Stock Summary

The Moving Average Convergence Divergence (MACD) for BCACU recently turned positive (within last 10 days).

An RSI reading of 70 or higher indicates an overbought or overvalued condition.

BCACU has less than 1 year of cash runway

In the News

11:50 10 Jun 2023 BCACU

Brookline Capital Acquisition Corp. Announces the Separate Trading of its Common Stock and Warrants, Commencing February 22, 2021

New York, NY, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Brookline Capital Acquisition Corp. (NASDAQ: BCACU) (the “Company”) announced today that, commencing February 22, 2021, holders of the 5,750,000 units sold in the Company's initial public offering may elect to separately trade shares of the Company's common stock and warrants included in the units. Common stock and warrants that are separated will trade on The Nasdaq Capital Market under the symbols “BCAC” and “BCACW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Those units not separated will continue to trade on The Nasdaq Capital Markets under the symbol “BCACU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into shares of common stock and warrants.

02:50 10 Jun 2023 BCACU

Brookline Capital Acquisition Corp. Completes Closing of $57,500,000 Initial Public Offering

New York, NY, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Brookline Capital Acquisition Corp. (NASDAQ: BCACU) (the “Company”) announced today that it closed its initial public offering of 5,750,000 units, including the exercise in full of the underwriters' 45-day option to purchase up to an additional 750,000 units. The offering was priced at $10.00 per unit, resulting in gross proceeds of $57,500,000.

05:50 10 Jun 2023 BCACU

Brookline Capital Acquisition Corp. Announces Pricing of $50,000,000 Initial Public Offering

New York, NY, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Brookline Capital Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of 5,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and will begin trading tomorrow, Friday, January 29, 2021, under the ticker symbol “BCACU”. Each unit consists of one share of the Company's common stock and one half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of common stock at a price of $11.50 per share. Only whole warrants are exercisable and will trade. Once the securities comprising the units begin separate trading, shares of the common stock and warrants are expected to be listed on Nasdaq under the symbols “BCAC” and “BCACW,” respectively.

BCACU Financial details

Company Rating

Market Cap

Income

-2.82M

Revenue

Book val./share

Cash/share

Dividend

Dividend %

Employees

Optionable

Shortable

Yes

Earnings

P/E

Forward P/E

PEG

P/S

P/B

P/C

P/FCF

Quick Ratio

1.16

Current Ratio

1.24

Debt / Equity

-1.08

LT Debt / Equity

EPS (TTM)

-0.09

EPS next Y

EPS next Q

EPS this Y

EPS next Y

EPS next 5Y

EPS last 5Y

Revenue last 5Y

Revenue Q/Q

EPS Q/Q

SMA20

SMA50

SMA100

Inst Own

Inst Trans

ROA

-626%

ROE

-3022%

ROC

-10.38%

Gross Margin

Oper. Margin

Profit Margin

Payout

Shs Outstand

2.45M

Shs Float

5.39M

Target Price

52W Range

52W High

52W Low

RSI

100

Rel Volume

Avg Volume

Volume

9.93K

Perf Week

Perf Month

Perf Quarter

Perf Half Y

123.51%

Beta

0.053908

Volatility

6.42%, 6.42%

Prev Close

Price

23.2

Change

129.93%

BCACU Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric	2020-12-31	2021-12-31
Revenue per share	0	0
Net income per share	0	0
Operating cash flow per share	0	0
Free cash flow per share	0	0
Cash per share	0	0
Book value per share	0	0
Tangible book value per share	0	0
Share holders equity per share	0	0
Interest debt per share	0	0
Market cap	0	0
Enterprise value	72.13K	-217.41
P/E ratio	0	0
Price to sales ratio	0	0
POCF ratio	0	0
PFCF ratio	0	0
P/B Ratio	0	0
PTB ratio	0	0
EV to sales	0	0
Enterprise value over EBITDA	0	0
EV to operating cash flow	0	0
EV to free cash flow	0	0
Earnings yield	0	0
Free cash flow yield	0	0
Debt to equity	3.03	49.28
Debt to assets	0.75	0
Net debt to EBITDA	0	0
Current ratio	0.01	1.24
Interest coverage	0	0
Income quality	0	0
Dividend Yield	0	0
Payout ratio	0	0
Sales general and administrative to revenue	0	0
Research and developement to revenue	0	0
Intangibles to total assets	0	0
Capex to operating cash flow	0	0
Capex to revenue	0	0
Capex to depreciation	0	0
Stock based compensation to revenue	0	0
Graham number	0	0
ROIC	0	-7.86
Return on tangible assets	0	-6.26
Graham Net	0	0
Working capital	-72.13K	44.12
Tangible asset value	24.15K	58.08K
Net current asset value	-72.13K	-5.54
Invested capital	3.03	0
Average receivables	0	0
Average payables	0	11.28
Average inventory	0	0
Days sales outstanding	0	0
Days payables outstanding	0	0
Days of inventory on hand	0	0
Receivables turnover	0	0
Payables turnover	0	0
Inventory turnover	0	0
ROE	0	-76.09K
Capex per share	0	0

Quarterly Fundamentals Overview

Last date of statement is 2022-03-31 for Q1

Metric	2021-06-30	2021-09-30	2021-12-31	2022-03-31
Revenue per share	0	0	0	0
Net income per share	0	0	0	0
Operating cash flow per share	0	0	0	0
Free cash flow per share	0	0	0	0
Cash per share	0	0	0	0
Book value per share	0	0	0	0
Tangible book value per share	0	0	0	0
Share holders equity per share	0	0	0	0
Interest debt per share	0	0	0	0
Market cap	0	0	0	0
Enterprise value	-352.13K	-274.49K	-217.41K	-93.32K
P/E ratio	0	0	0	0
Price to sales ratio	0	0	0	0
POCF ratio	0	0	0	0
PFCF ratio	0	0	0	0
P/B Ratio	0	0	0	0
PTB ratio	0	0	0	0
EV to sales	0	0	0	0
Enterprise value over EBITDA	1.25	-3.64	0.79	0.04
EV to operating cash flow	5.11	3.54	0	0.75
EV to free cash flow	5.11	3.54	0	0.75
Earnings yield	0	0	0	0
Free cash flow yield	0	0	0	0
Debt to equity	0.01	0	49.28	-1.08
Debt to assets	0.01	0	0	0.05
Net debt to EBITDA	1.25	-3.64	0.79	0.04
Current ratio	4.2	2.33	1.24	0.07
Interest coverage	0	0	0	0
Income quality	0.24	-1.03	0	0.05
Dividend Yield	0	0	0	0
Payout ratio	0	0	0	0
Sales general and administrative to revenue	0	0	0	0
Research and developement to revenue	0	0	0	0
Intangibles to total assets	0	0	0	0
Capex to operating cash flow	0	0	0	0
Capex to revenue	0	0	0	0
Capex to depreciation	0	0	0	0
Stock based compensation to revenue	0	0	0	0
Graham number	0	0	0	0
ROIC	0	-0.01	0	-0.04
Return on tangible assets	-0.01	0.01	0	-0.04
Graham Net	0	0	0	0
Working capital	361.1K	195.1K	44.12K	-2.41M
Tangible asset value	58.11M	58.19M	58.08M	55.62M
Net current asset value	32.58K	108.76K	-5.54K	-2.47M
Invested capital	0	0	0	0
Average receivables	0	0	0	0
Average payables	0	28.55K	26.42K	65.58K
Average inventory	0	0	0	0
Days sales outstanding	0	0	0	0
Days payables outstanding	0	0	0	0
Days of inventory on hand	0	0	0	0
Receivables turnover	0	0	0	0
Payables turnover	0	0	0	0
Inventory turnover	0	0	0	0
ROE	-0.01	0.01	-58.58	1
Capex per share	0	0	0	0

BCACU Frequently Asked Questions

What is Brookline Capital Acquisition Corp. stock symbol ?

Brookline Capital Acquisition Corp. is a US stock and trading under the symbol BCACU

What is Brookline Capital Acquisition Corp. stock quote today ?

Brookline Capital Acquisition Corp. stock price is $23.2 today.

Is Brookline Capital Acquisition Corp. stock public?

Yes, Brookline Capital Acquisition Corp. is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Check Those

Similar Market Cap

Company Profile

CEO James Jiayuan Tong
Headquarters US
IPO Date 2021-01-29
Website https://www.brooklinecapitalacquisitioncorp.com

Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.